Spectra Energy Corp. (NYSE:SE) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN) To Posts Lower Results


Spectra Energy Corp. (NYSE:SE) is aim to posts a lower results against a year before what time it announced its Q1 earnings on Friday, May 3, 2013 as also analysts are predicting for lower profit. Spectra declared profit of 51 cents a year before, but the consensus anticipates calls for earnings per share of 48 cents this time around.

The consensus predicts has dropped over the previous quarter from 49 cents. The analysts are predicting earnings of $1.52 a share for the fiscal year. Revenue is anticipated to conceal the year-earlier total of $1.54B by 0.4 percent, finishing at $1.55B for the quarter. The revenue is anticipated to roll in at $5.35B for the year.

The firm has announced falling revenue for Q4 in a row. Revenue in Q4 of the previous fiscal year was $1.35B, a decrease of 5.7 percent year-over-year.

While Leading up to Regeneron Pharmaceuticals Inc (NASDAQ:REGN) declaration of its Q1 earnings on Friday, experts have become more bullish as anticipations have surged over the previous month from 95 cents per share to the present anticipations of earnings of $1.02 a share.

The present anticipates reflects a 537.5 percent surge from a year before, at what time the firm declared earnings of 16 cents a share.

The consensus predicts has dropped from $1.14 in excess of the previous quarter. The analysts are predicting earnings of $4.59 a share for the fiscal year. Revenue is anticipate to be $424.3M for the quarter, 83 percent above the year-earlier total of $231.8M. The revenue is anticipated to come in at $1.91B for the year.


Leave a Reply

Your email address will not be published. Required fields are marked *